Navigation Links
NON-INVASIVE BABY GENDER TEST

ProductsNON-INVASIVE BABY GENDER TEST
Company Paragon Genetics
Item NON-INVASIVE BABY GENDER TEST
Features 
  • Analysis of cell-free fetal DNA in maternal blood samples is a screening test that is a non-invasive prenatal procedure and poses no risks to the mother or the fetus. The non-invasive gender test is based on the detection of Y chromosome-specific DNA in maternal plasma samples.
  • This DNA gender identity test is relatively inexpensive in comparison to invasive techniques such as CVS or amniocentesis.
Description The current available techniques for prenatal diagnosis (CVS and amniocentesis) are invasive and carry with their use a small but significant chance of miscarriage. As a result, the current standard care offers invasive prenatal baby gender testing only to those women whose risk of chromosomal or genetic abnormalities are greater than or equal to the risk of a procedure-related loss. This means that the vast majority of women never receive the benefits of gender prediction. The recent discovery of the presence of cell-free fetal DNA in maternal plasma has offered new approaches to non-invasive prenatal diagnosis. The concentration of cell-free fetal DNA in maternal plasma was found to be much higher than that present in the cellular fraction. Given the relatively easy identification of male DNA in maternal plasma, one clinical application is the non-invasive identification of male fetuses at risk for X-linked disorders. The second is a curiosity application for the parents who would like to know the gender of the baby.
Info Paragon Genetics
Customer Service: (866) 362-0577
Web site: http://www.paragondna.com/prenatal/index.asp

Related medicine products :

1. 0237 VixOne Infant Nebulizer Kit
2. 0236 VixOne Infant Nebulizer Kit
3. VixOne Infant Extension Set
4. 0207 VixOne Nebulizer
5. 0209 VixOne Nebulizer
6. 0215 VixOne Nebulizer
7. 0217 VixOne Nebulizer
8. 0210 VixOne Nebulizer
9. 0310 VixOne Nebulizer
10. 0222 VixOne Nebulizer
11. 0311 VixOne Nebulizer
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
... hand-held, point-of-care device for the qualitative detection of ... The TOX/See device can detect up to nine ... to 8 minutes and requires only a few ... packaged to maximize convenience and ease of use. ...
Medicine Products:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment ... Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... General Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: